newsfilter
← Latest News
PR Newswire·

LumiraDx Announces Pricing of Public Offering of Common Shares and Concurrent Private Placement

LONDON, July 21, 2022 /PRNewswire/ -- LumiraDx Limited (NASDAQ:LMDX), a next-generation point of care (POC) diagnostics company, today announced the pricing of its underwritten public offering of 43,000,000 common shares at a price to the public of $1.7